Clinical outcomes of patients with mut-type methylmalonic acidemia identified through expanded newborn screening in China

Shiying Ling,Shengnan Wu,Ruixue Shuai,Yue Yu,Wenjuan Qiu,Haiyan Wei,Chiju Yang,Peng Xu,Hui Zou,Jizhen Feng,Tingting Niu,Haili Hu,Huiwen Zhang,Lili Liang,Yu Wang,Ting Chen,Feng Xu,Xuefan Gu,Lianshu Han
DOI: https://doi.org/10.1186/s40246-024-00646-0
2024-07-31
Human Genomics
Abstract:Isolated methylmalonic acidemia, an autosomal recessive disorder of propionate metabolism, is usually caused by mutations in the methylmalonyl-CoA mutase gene (mut-type). Because no universal consensus was made on whether mut -type methylmalonic acidemia should be included in newborn screening (NBS), we aimed to compare the outcome of this disorder detected by NBS with that detected clinically and investigate the influence of NBS on the disease course.
genetics & heredity
What problem does this paper attempt to address?